Pedro Torres-Ayuso

9PUBLICATIONS
44CO-AUTHORS
Solid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 27, 2026
TNIK maintains a MYC-driven partial EMT state that supports proliferation and evasion of senescence in lung squamous cell carcinoma.

|Jun 02, 2026
Suppression of AKT Activation Through LZK Inhibition Limits Tumor Growth in Esophageal and Head and Neck Cancers.

|Apr 26, 2024
TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy.

Triet Nguyen, Francesca A Carrieri, Nick Connis

|Mar 08, 2024
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models.

Feng Ren, Alex Aliper, Jian Chen

|Jan 26, 2021
TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin.

Pedro Torres-Ayuso, Elvira An, Katherine M Nyswaner

|Dec 11, 2019
Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic Targets.

Pedro Torres-Ayuso, John Brognard

Pageof 2

Frequent Collaborators

3 joint publications

John Brognard

2 joint publications

Tung Hoang

2 joint publications

Amol C Shetty

2 joint publications

Shreya Jagtap